Genomics Inform.
2014 Dec;12(4):247-253. 10.5808/GI.2014.12.4.247.
Analysis of Gene Expression in Cyclooxygenase-2-Overexpressed Human Osteosarcoma Cell Lines
- Affiliations
-
- 1Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine, Chuncheon 200-701, Korea.
- 2Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, Korea.
- 3Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul 110-799, Korea. jongil@snu.ac.kr
- 4Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 110-799, Korea.
- 5Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul 110-799, Korea.
- KMID: 2391504
- DOI: http://doi.org/10.5808/GI.2014.12.4.247
Abstract
- Osteosarcoma is the most common primary bone tumor, generally affecting young people. While the etiology of osteosarcoma has been largely unknown, recent studies have suggested that cyclooxygenase-2 (COX-2) plays a critical role in the proliferation, migration, and invasion of osteosarcoma cells. To understand the mechanism of action of COX-2 in the pathogenesis of osteosarcoma, we compared gene expression patterns between three stable COX-2-overexpressing cell lines and three control cell lines derived from U2OS human osteosarcoma cells. The data showed that 56 genes were upregulated, whereas 20 genes were downregulated, in COX-2-overexpressed cell lines, with an average fold-change > 1.5. Among the upregulated genes, COL1A1, COL5A2, FBN1, HOXD10, RUNX2, and TRAPPC2are involved in bone and skeletal system development, while DDR2, RAC2, RUNX2, and TSPAN31are involved in the positive regulation of cell proliferation. Among the downregulated genes, HIST1H1D, HIST1H2AI, HIST1H3H, and HIST1H4C are involved in nucleosome assembly and DNA packaging. These results may provide useful information to elucidate the molecular mechanism of the COX-2-mediated malignant phenotype in osteosarcoma.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Analysis of RECK (a novel MMP inhibitor) Expression and its Roles as a Biomarker and Evaluation of RECK as a Potential Therapeutic Agent for Osteosarcoma
- TGF - beta Type II Receptor Anomaly and of Its Functional Restoration in Osteosarcoma Cell Lines
- The Role of CTGF in Osteosarcoma Progression
- Identification of Stem Cell Related Gene Expression from the Osteosarcoma Cell Core Side
- ERK1/2 Activation Modulates Matrix Metalloproteinase 2 Activity and Ezrin Expression in Osteosarcoma Cell Lines
